Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.

Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.

Item
http://www.wikidata.org/entity/Q36432030
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencingInhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases.Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts.Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors.PAX3 and FOXD3 Promote CXCR4 Expression in MelanomaCCR7 regulates B16 murine melanoma cell tumorigenesis in skinInhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases.The good and the bad of chemokines/chemokine receptors in melanoma.CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors.Chemokine-chemokine receptors in cancer immunotherapy.The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines.Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors.Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy.
P2860

Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.

Item
http://www.wikidata.org/entity/Q36432030
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Sensitization of B16 tumor cel ...... r established lung metastases.
@ast
Sensitization of B16 tumor cel ...... r established lung metastases.
@en
type
label
Sensitization of B16 tumor cel ...... r established lung metastases.
@ast
Sensitization of B16 tumor cel ...... r established lung metastases.
@en
prefLabel
Sensitization of B16 tumor cel ...... r established lung metastases.
@ast
Sensitization of B16 tumor cel ...... r established lung metastases.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Sensitization of B16 tumor cel ...... or established lung metastases
@en
P2093
P2860
P304
P31
P356
10.1158/1535-7163.MCT-06-0310
P433
P478
P50
P577
P698
P921
P932